Spur Therapeutics
Phase 1/2Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of diseases—and change lives.
Founded
2021
Focus
RNA & Gene Therapy
About
Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of diseases—and change lives.
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePhase 1/2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile